<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Progress</title>
	<atom:link href="http://www.tapanray.in/tag/progress/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Creating ‘Shared Value’ in Pharma – The Way Forward</title>
		<link>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=creating-shared-value-in-pharma-the-way-forward</link>
		<comments>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/#comments</comments>
		<pubDate>Mon, 30 Jul 2018 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[Arogya]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[creation]]></category>
		<category><![CDATA[CSR]]></category>
		<category><![CDATA[Declining]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Parivar]]></category>
		<category><![CDATA[philanthropy]]></category>
		<category><![CDATA[prices]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[shared]]></category>
		<category><![CDATA[social responsibility]]></category>
		<category><![CDATA[social. society]]></category>
		<category><![CDATA[sustainable]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[trust]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9079</guid>
		<description><![CDATA[Many Pharmaceutical companies, both global and local, are struggling with a plethora of critical challenges. With the industry reputation diving south successful navigation through this headwind has become an onerous task, more than ever before. Under this backdrop, the article, &#8230; <a href="http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug, Patent and Hype: Quo Vadis Pharma Innovation?</title>
		<link>http://www.tapanray.in/drug-patent-and-hype-quo-vadis-pharma-innovation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=drug-patent-and-hype-quo-vadis-pharma-innovation</link>
		<comments>http://www.tapanray.in/drug-patent-and-hype-quo-vadis-pharma-innovation/#comments</comments>
		<pubDate>Sun, 20 Oct 2013 18:30:52 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[associations]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Columbia]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[discover]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[Glivec]]></category>
		<category><![CDATA[Hype]]></category>
		<category><![CDATA[indications]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Judgment]]></category>
		<category><![CDATA[Nature]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Patentable]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[placebo]]></category>
		<category><![CDATA[Prescire]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[profit]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Reviews]]></category>
		<category><![CDATA[sans]]></category>
		<category><![CDATA[Section(3d)]]></category>
		<category><![CDATA[states]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[United]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[US]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2704</guid>
		<description><![CDATA[A recent research report reveals, though the pharmaceutical companies in the United States since mid 2000 have spent over US$ 50 billion every year to discover new drugs, they have very rarely been able to invent something, which can be called significant &#8230; <a href="http://www.tapanray.in/drug-patent-and-hype-quo-vadis-pharma-innovation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/drug-patent-and-hype-quo-vadis-pharma-innovation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Progress of the ‘Millennium Development Goals (MDGs)’ in India: a little to cheer, more to ponder</title>
		<link>http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder</link>
		<comments>http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/#comments</comments>
		<pubDate>Mon, 20 Sep 2010 00:30:05 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[cheer]]></category>
		<category><![CDATA[CMR]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[goals]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[little]]></category>
		<category><![CDATA[MDGs]]></category>
		<category><![CDATA[millennium]]></category>
		<category><![CDATA[MME]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[ponder]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=372</guid>
		<description><![CDATA[The world has just five more years to achieve the ‘Millennium Development Goals (MDGs)’. To accelerate progress of this unique United Nation’s initiative the UN Secretary-General Ban Ki-moon has called on world leaders to attend a summit in New York &#8230; <a href="http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare reform process and policy measures to reduce socio-economic inequalities should be implemented in tandem for optimal economic progress of a nation.</title>
		<link>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation</link>
		<comments>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 00:30:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[implemented]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequalities]]></category>
		<category><![CDATA[measures]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[optimal]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reduce]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[tandem]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=771</guid>
		<description><![CDATA[Important research studies indicate that health of an individual is as much an integral function of the related socio-economic factors as it is influenced by the person’s life style and genomic configurations.It has now been well established that socio-economic disparities &#8230; <a href="http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An image makeover is in progress in the global pharmaceutical industry.</title>
		<link>http://www.tapanray.in/an-image-makeover-is-in-progress-in-the-global-pharmaceutical-industry/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=an-image-makeover-is-in-progress-in-the-global-pharmaceutical-industry</link>
		<comments>http://www.tapanray.in/an-image-makeover-is-in-progress-in-the-global-pharmaceutical-industry/#comments</comments>
		<pubDate>Sun, 16 Aug 2009 01:03:56 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[makeover]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=766</guid>
		<description><![CDATA[At the beginning of 2009, Andrew Witty, the young head honcho of Glaxo SmithKline (GSK) initiated a one CEO tirade to recognize the global poor as a stakeholder of the global pharmaceutical industry. The industry that has been much maligned &#8230; <a href="http://www.tapanray.in/an-image-makeover-is-in-progress-in-the-global-pharmaceutical-industry/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/an-image-makeover-is-in-progress-in-the-global-pharmaceutical-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
